Criteria & Principles
Rapid molecular diagnostic technologies for infectious diseases have dramatically reduced the time to pathogen identification thus allowing for earlier ‘targeting’ of therapy to the most effective agent. ASET is working diligently with DUH Microbiology to bring additional rapid diagnostics to Duke.
Please find information attached about our two newest rapid diagnostic technologies:
BioFire Blood Culture (BCID): Go Live December, 4, 2018
BioFire Meninigitis/Encephalitis Panel (Go Live -Aug 14, 2017)
BioFire GI Panel (Go Live - pending).